Smith & Nephew PLC (SN.)

Industry Medical Devices

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,140.00p

Buy

1,140.50p

arrow-down-4.50p (-0.39%)

Prices updated at 22 May 2026, 17:01 BST

Prices minimum 15 mins delay

Prices in GBX

Smith & Nephew PLC designs, manufactures, and markets orthopedic devices and wound-care solutions. Its products include knee replacements, hip implants, nails, fixation devices, arthroscopy tools and others.

FTSE All-Share

0.3%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	5,810m	6,164m
	4,046m	4,192m
	860m	857m
	14.80	13.90
	412m	625m
	1,221m	1,532m
Sales, General and administrative	2,652m	2,790m
Interest expenses	168m	179m
Provision for income taxes	86m	154m
Operating expenses	3,186m	3,335m
Income before taxes	498m	779m
Net income available to common shareholders	412m	625m
	0.472	0.721
Net interest income	-149m	-128m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.47	0.716
Free cash flow per share	0.2747	0.6732
Book value/share	4.7489	4.8403
Debt equity ratio	0.618803	0.600681

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	4,421m	4,103m
Current liabilities	1,531m	1,595m
Total capital	8,388m	8,317m
Total debt	3,321m	3,327m
Total equity	5,265m	5,289m
Total non current liabilities	-	-
Loans	3,123m	3,028m
Total assets	10,354m	10,457m
Total liabilities	-	-
Cash and cash equivalents	619m	557m
Common stock	873m	849m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	300m	617m
Cash dividends paid	-327m	-330m
	606m	852m
Investments (gains) losses	-569m	-406m
	617m	553m
Net income	-	-
	987m	1,285m
	-381m	-433m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.